Lexicon Pharmaceuticals | LXRX - Процентные расходы





Процентные расходы Изменить Дата
Abbott USD 299M 231M 2026-06
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Akebia Therapeutics 349.66M 12.86M 2026-06
Alnylam Pharmaceuticals USD 82.05M 12.76M 2026-06
AstraZeneca USD 340M 144M 2026-06
BioMarin Pharmaceutical USD 63.29M 48.34M 2026-06
Coherus Biosciences USD 2.25M 76K 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Halozyme Therapeutics USD 5.59M 80K 2026-06
Illumina USD 24M 2M 2026-03
Insmed USD 18.84M 1.24M 2026-06
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
J&J USD 43M 25M 2026-03
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
MacroGenics USD 4.89M 1.55M 2026-03
MannKind USD 14.82M 2.38M 2026-06
Merck USD 525M 46M 2026-06
Moderna USD 10.96B 527M 2026-06
Novartis USD 462M 119M 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Puma Biotechnology USD 3.37M 11K 2024-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Thermo Fisher Scientific USD 354M 11M 2026-03
Ultragenyx Pharmaceutical USD 22M 1000K 2026-06
United Therapeutics USD 2.9M 200K 2026-06
Vanda Pharmaceuticals -1.37B 1.97B 2025-12